Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1982 3
1984 1
1987 3
1988 2
1989 1
1990 4
1991 2
1992 3
1993 6
1994 1
1995 4
1996 1
1997 4
1998 5
1999 4
2000 3
2001 2
2002 3
2003 2
2005 1
2006 1
2011 1
2012 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

60 results

Results by year

Filters applied: . Clear all
Page 1
Pharmacological treatments in panic disorder in adults: a network meta-analysis.
Guaiana G, Meader N, Barbui C, Davies SJ, Furukawa TA, Imai H, Dias S, Caldwell DM, Koesters M, Tajika A, Bighelli I, Pompoli A, Cipriani A, Dawson S, Robertson L. Guaiana G, et al. Cochrane Database Syst Rev. 2023 Nov 28;11(11):CD012729. doi: 10.1002/14651858.CD012729.pub3. Cochrane Database Syst Rev. 2023. PMID: 38014714 Free article. Review.
Panic disorder is common in the general population with a prevalence of 1% to 4%. ...OBJECTIVES: To compare, via network meta-analysis, individual drugs (antidepressants and benzodiazepines) or placebo in terms of efficacy and acceptability in the acute treatment of …
Panic disorder is common in the general population with a prevalence of 1% to 4%. ...OBJECTIVES: To compare, via network meta- …
Panic attacks and agoraphobia: low dose clomipramine treatment.
Gloger S, Grunhaus L, Gladic D, O'Ryan F, Cohen L, Codner S. Gloger S, et al. J Clin Psychopharmacol. 1989 Feb;9(1):28-32. J Clin Psychopharmacol. 1989. PMID: 2651491 Clinical Trial.
Seventeen outpatients with panic anxiety and agoraphobia were treated with a low, flexible dose of clomipramine in an 8-week open trial. Panic attacks ceased completely in 13 patients and markedly decreased in the other four without additional t …
Seventeen outpatients with panic anxiety and agoraphobia were treated with a low, flexible dose of clomipramine in an 8 …
Clomipramine, a better reference drug for panic/agoraphobia. I. Effectiveness comparison with imipramine.
Gentil V, Lotufo-Neto F, Andrade L, Cordás T, Bernik M, Ramos R, Maciel L, Miyakawa E, Gorenstein C. Gentil V, et al. J Psychopharmacol. 1993 Jan;7(4):316-24. doi: 10.1177/026988119300700402. J Psychopharmacol. 1993. PMID: 22290994
An 8-week, double-blind, flexible-dose trial comparing low doses of clomipramine (mean=50 mg) with moderate doses of imipramine (mean=113.8 mg and propanteline (active placebo), was carried out in 60 out-patients with panic disorder with or without agoraph …
An 8-week, double-blind, flexible-dose trial comparing low doses of clomipramine (mean=50 mg) with moderate doses of imipramine (mean …
Antidepressant drugs in anxiety disorders.
Modigh K. Modigh K. Acta Psychiatr Scand Suppl. 1987;335:57-74. doi: 10.1111/j.1600-0447.1987.tb07749.x. Acta Psychiatr Scand Suppl. 1987. PMID: 3314359 Review.
The efficacy of tricyclic antidepressants and monoamine oxidase inhibitors (MAOI) in the treatment of panic syndromes (panic disorder and agoraphobia with panic attacks) and obsessive-compulsive disorders is reviewed. Imipramine has been …
The efficacy of tricyclic antidepressants and monoamine oxidase inhibitors (MAOI) in the treatment of panic syndromes (panic …
Treatment strategies of obsessive-compulsive disorder and panic disorder/agoraphobia.
Marazziti D, Carlini M, Dell'Osso L. Marazziti D, et al. Curr Top Med Chem. 2012;12(4):238-53. doi: 10.2174/1568026799078688. Curr Top Med Chem. 2012. PMID: 22204483 Review.
This paper aims to provide a comprehensive review of recommendations for the pharmacological treatment of two common anxiety disorders, in particular obsessive-compulsive disorder (OCD) and panic disorder (PD). The first-line treatments of OCD include medium- …
This paper aims to provide a comprehensive review of recommendations for the pharmacological treatment of two common anxiety disorders, in p …
Clomipramine treatment for panic attacks in patients with mitral valve prolapse.
Grunhaus L, Gloger S, Birmacher B. Grunhaus L, et al. J Clin Psychiatry. 1984 Jan;45(1):25-7. J Clin Psychiatry. 1984. PMID: 6363396 Clinical Trial.
Clomipramine (25-150 mg/day) was given in a 2-month open clinical trial to patients with DSM-III defined panic disorder (N = 8) or agoraphobia with panic attacks (N = 12); 6 of these patients were found to have MVP. Substantial improvemen …
Clomipramine (25-150 mg/day) was given in a 2-month open clinical trial to patients with DSM-III defined panic disorder …
Clomipramine. An overview of its pharmacological properties and a review of its therapeutic use in obsessive compulsive disorder and panic disorder.
McTavish D, Benfield P. McTavish D, et al. Drugs. 1990 Jan;39(1):136-53. doi: 10.2165/00003495-199039010-00010. Drugs. 1990. PMID: 2178909 Review.
However, in addition to its role as an antidepressant, attention is being focused on the use of clomipramine in 2 other areas of psychiatry: obsessive compulsive disorder and panic disorder. ...In patients with panic disorder with or with …
However, in addition to its role as an antidepressant, attention is being focused on the use of clomipramine in 2 other areas of psyc …
Clomipramine, a better reference drug for panic/agoraphobia. II. Psychomotor and cognitive effects.
Marcourakis T, Gorenstein C, Gentil V. Marcourakis T, et al. J Psychopharmacol. 1993 Jan;7(4):325-30. doi: 10.1177/026988119300700403. J Psychopharmacol. 1993. PMID: 22290995
The present reference drugs for the treatment of panic disorder and agoraphobia are imipramine and alprazolam. The latter decreases performance and cognitive functioning. No study of such functions in panic/agoraphobia is available. Fifty four o …
The present reference drugs for the treatment of panic disorder and agoraphobia are imipramine and alprazolam. The latt …
The use of the Panic and Agoraphobia Scale (P & A) in a controlled clinical trial.
Bandelow B, Broocks A, Pekrun G, George A, Meyer T, Pralle L, Bartmann U, Hillmer-Vogel U, Rüther E. Bandelow B, et al. Pharmacopsychiatry. 2000 Sep;33(5):174-81. doi: 10.1055/s-2000-12982. Pharmacopsychiatry. 2000. PMID: 11071019 Clinical Trial.
BACKGROUND: A new 13-item scale has been developed for measuring severity of illness in patients with panic disorder and agoraphobia, the Panic and Agoraphobia Scale (P & A). The scale has five subscales covering the main factors that reduce …
BACKGROUND: A new 13-item scale has been developed for measuring severity of illness in patients with panic disorder and ag …
Clomipramine treatment of panic disorder: pros and cons.
Papp LA, Schneier FR, Fyer AJ, Leibowitz MR, Gorman JM, Coplan JD, Campeas R, Fallon BA, Klein DF. Papp LA, et al. J Clin Psychiatry. 1997 Oct;58(10):423-5. doi: 10.4088/jcp.v58n1002. J Clin Psychiatry. 1997. PMID: 9375591 Clinical Trial.
BACKGROUND: Controlled trials suggest that clomipramine may be a highly effective antipanic drug. Lowering the starting dose may alleviate troublesome initial side effects and increase acceptability and compliance. METHOD: Fifty-eight patients with DSM-III-R panic …
BACKGROUND: Controlled trials suggest that clomipramine may be a highly effective antipanic drug. Lowering the starting dose may alle …
60 results